BMO raises Brookfield Business stock price target on portfolio value

BMO Capital raised its price target on Brookfield Business Corp to $44 from $43 while keeping an Outperform rating, implying about 46% upside from the $30.13 share price. The firm said portfolio value appears underappreciated, pro forma liquidity is strong, and financial performance should step up in 2027, though some assumptions were made more conservative for investments like CDK. The stock is down 9.2% over the past week despite the higher target and the company’s recent court-approved reorganization into NYSE:BBUC.

Analysis

The key signal here is not the modest target hike; it is the market’s continued failure to monetize Brookfield’s embedded optionality. If liquidity is genuinely ample and capital recycling remains active, the equity should trade less like a static asset-holdco and more like a compounding platform with multiple monetization events ahead. That creates a second-order setup where incremental confidence in realization timing can re-rate the stock faster than underlying operating earnings growth would justify.

The market is likely anchored to the near-term optics of slower reported earnings power, which keeps the multiple compressed even as portfolio quality improves. The biggest upside lever is a cleaner path to perceived NAV realization through asset sales, recapitalizations, or partial monetizations; once that narrative becomes visible, the discount can narrow sharply because the current valuation leaves room for a meaningful rerating. The downside is that any delay in monetization pushes the bull case further into the future, which matters in a market that is punishing long-duration stories.

The contrarian view is that consensus may be overestimating how quickly “underappreciated value” becomes tradable value. If 2027 is the inflection rather than the present, the stock may remain range-bound until there is proof of execution, not just optimism about portfolio health. That makes this a timing trade more than a pure valuation trade: the catalyst path needs to stay intact, or the shares can quickly revert to being viewed as a complex structure with a persistent holding-company discount.

Key Decisions for Investors

• Long BBUC on weakness with a 3-6 month horizon; use a staggered entry near post-news pullbacks, targeting a re-rating toward the revised valuation band as monetization credibility improves.
• Buy BBUC call spreads 6-12 months out to express upside while limiting theta if the market waits for 2027 evidence; risk/reward is best if the stock remains range-bound in the near term but breaks higher on a recycling catalyst.
• Pair trade: long BBUC / short a basket of lower-quality holding-company or complex-conglomerate names; the relative trade benefits if the market rewards visible NAV realization and liquidity over opaque asset mixes.
• Trim or avoid chasing BBUC after sharp rallies; the thesis is catalyst-driven, so upside is likely stepwise rather than linear, and entry discipline matters more than conviction.
• Set a trigger to add only if management demonstrates incremental capital recycling or a valuation unlock event; without that, treat the position as a watchlist name rather than a full-size core long.